Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking Africa

NCT ID: NCT03803735

Last Updated: 2025-10-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

10000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-01-01

Study Completion Date

2030-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The ultimate aim of this registry is to collect precise information concerning the children coming to oncology units working with the French African Oncology Group. This data will help to plan and provide correct pediatric oncology treatment and care for this population.

Collecting the data will give much needed information on numbers, stage, treatment and outcome. The register will give data for local and national health authorities in planning pediatric cancer programs.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This register is a registration of all children entering hospital based pediatric oncology units, working in selected hospitals in French speaking Africa. The data collected includes: demographic and socioeconomic status as well as clinical status and outcome.

The register also collects information on vital status, treatment abandonment and loss to follow-up.

Data, collected locally is entered on line using the Research Electronic Data Capture (REDCap) program. Data are stored under the responsibility of the IT department at Gustave ROUSSY in Paris- Villejuif.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pediatric Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Any child presenting at any one of the participating units for treatment
2. Any child with any type of cancer
3. Any child or adolescent less than 18 years of age.

Exclusion Criteria

1. No cancer found
2. Age greater than 18 years -
Minimum Eligible Age

1 Day

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Gustave Roussy, Cancer Campus, Grand Paris

OTHER

Sponsor Role collaborator

French Africa Pediatric Oncology Group

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Brenda Mallon, MSc

Role: STUDY_DIRECTOR

French Africa Pediatric Oncology Group

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hopital Yalgado Ouedraogo

Ouagadougou, , Burkina Faso

Site Status RECRUITING

Centre Hospitalier Universitaire Pédiatrique Charles De Gaulle

Ouagadougou, , Burkina Faso

Site Status RECRUITING

Centre Mère et Enfant CME-FCB (Fondation Chantal Biya)

Yaoundé, , Cameroon

Site Status RECRUITING

CHU de Treichville à ABIDJAN

Abidjan, Abidjan Autonomous District, Côte d’Ivoire

Site Status RECRUITING

Cliniques Universitaires de Kinshasa

Kinshasa, Kinshasa City, Democratic Republic of the Congo

Site Status RECRUITING

Cliniques Universitaires de Lubumbashi (CUL)

Lubumbashi, , Democratic Republic of the Congo

Site Status RECRUITING

GFAOP

Villejuif, PARIS, France

Site Status RECRUITING

l'Institut de Cancérologie de Libreville

Libreville, , Gabon

Site Status RECRUITING

HJRA, Hôpital universitaire Joseph Ravoahangy Andrianavalona

Antananarivo, Ampefiloha, Madagascar

Site Status RECRUITING

CHU Gabriel Touré (HGT)

Bamako, , Mali

Site Status RECRUITING

Centre National d'Oncologie (CNO)

Nouakchott, , Mauritania

Site Status RECRUITING

CNLC, Centre National de Lutte contre le Cancer

Niamey, , Niger

Site Status RECRUITING

Hôpital Aristide Le Dantec, Avenue Pasteur, BP 3001

Dakar, Dakar, Senegal

Site Status RECRUITING

CHU Sylvanus Olympio

Lomé, , Togo

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Burkina Faso Cameroon Côte d’Ivoire Democratic Republic of the Congo France Gabon Madagascar Mali Mauritania Niger Senegal Togo

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Brenda MALLON, MSC

Role: CONTACT

+ 33142115411

Catherine PATTE, DR

Role: CONTACT

+ 33142116560

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

BOUDA CHANTAL, DR

Role: primary

Sonia Ms Kaboret, Dr

Role: primary

[email protected]

Role: backup

Angèle PONDY, PROFESSEU

Role: primary

237) 677 030 892

Line Guei COUITCHERE, MD

Role: primary

BUDIONGO Aléine, DR

Role: primary

Robert LUKAMBA, DR

Role: primary

00(243) 814024633

BRENDA MALLON, MSC

Role: primary

0033661519474

CATHERINE PATTE, DR

Role: backup

0033142116560

Betty NDAKISSA, DR

Role: primary

Mbola RAKOTOMAHEFA, DR

Role: primary

(261) 33 05 055 66

Boubacar TOGO, PROFESSEUR

Role: primary

+223 66 74 29 04

Ekhtel Benina ZEIN, DR

Role: primary

222 45 24 22 32

Aichatou MAHAMADOU, DR

Role: primary

DIAGNE AKONDE Fatou-Binetou, Dr

Role: primary

00(221)77 637 40 63

Koffi Mawuse Jules GUEDENON, DR

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GFAOP

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Tumor and Development (TED)
NCT01915797 COMPLETED
French Wilson Disease Registry
NCT05231876 RECRUITING